Oss, Netherlands

Rogier Christian Buijsman

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • MK Berghem, NL (2019)
  • Berghem, NL (2020)
  • Oss, NL (2002 - 2024)

Company Filing History:


Years Active: 2002-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Rogier Christian Buijsman

Introduction

Rogier Christian Buijsman is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can be utilized in cancer treatment. With a total of nine patents to his name, Buijsman has established himself as a key figure in innovation.

Latest Patents

Among his latest patents are the compounds known as (5,6-dihydro)pyrimido[4,5-e]indolizines. These compounds are characterized by a specific formula where R and R are independently selected from a group consisting of optionally substituted (6-10C) aryl and (1-5C) heteroaryl groups. The potential applications of these compounds lie in pharmaceutical compositions, particularly for the treatment of cancer.

Career Highlights

Buijsman has worked with the Netherlands Translational Research Center B.V., where he has contributed to various research initiatives. His work has focused on the intersection of chemistry and medicine, leading to advancements in therapeutic options for cancer patients.

Collaborations

Throughout his career, Buijsman has collaborated with notable individuals such as Adrianus Petrus Antonius De Man and Guido Jenny Rudolf Zaman. These collaborations have further enriched his research and development efforts.

Conclusion

Rogier Christian Buijsman is a distinguished inventor whose work in pharmaceutical innovation has the potential to impact cancer treatment significantly. His contributions through patents and collaborations highlight the importance of research in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…